Thank you for considering the Journal of Medical and Perioperative Critical Care (JMPCC). Please read these instructions carefully; manuscripts that do not follow them will be returned before peer review. JMPCC follows the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.

1. Before you submit

•     Check that your work fits the Aims & Scope.

•     The manuscript must be original, not previously published (except as a preprint, thesis or conference abstract) and not under consideration elsewhere.

•     All authors meet the authorship criteria and approve the submission.

•     Ethics approval, informed consent (or an approved alternative for patients unable to consent), and trial registration are in place where required.

•     For case reports, clinical images and case series: written consent for publication has been obtained (see the Case Reports policy).

2. Manuscript structure

Original research and trials

•     Structured abstract (Background, Methods, Results, Conclusions), including the trial registration number for trials.

•     Keywords: 4–6, preferably MeSH terms.

•     Introduction, Methods (design, setting, dates, participants and eligibility, interventions with drug doses and timing, outcomes with definitions, sample size calculation, randomisation and blinding, statistical analysis, ethics and consent), Results, Discussion (including limitations), Conclusions.

•     Report physiological and laboratory values in SI units (with conventional units in brackets if helpful), drug doses per kg where relevant, and ventilator settings in full (mode, tidal volume per kg predicted body weight, PEEP, FiO2).

Case reports (follow CARE)

•     Title containing the words ‘case report’.

•     Structured abstract, 3–5 keywords.

•     Introduction: why the case is new or important.

•     Patient information (de-identified), clinical findings, timeline, diagnostic assessment, anaesthetic or ICU management, follow-up and outcomes.

•     Discussion with review of relevant literature, strengths and limitations.

•     Patient perspective (encouraged), learning points (2–4), and a consent statement.

3. Style

•     English (British or American, consistently). Language quality alone does not lead to rejection when the science is sound.

•     Word format, 12-point font, double spacing, line and page numbers.

•     Generic (non-proprietary) drug names. Device names may be given with manufacturer, city and country at first mention.

•     Abbreviations defined at first use; avoid non-standard abbreviations.

•     Use respectful, person-first language.

References

Vancouver (ICMJE/NLM) style, numbered in order of citation, with DOIs where available. Guidelines should be cited with the issuing body, year and URL. Authors are responsible for accuracy; unverifiable references will be queried.

Submissions and editorial correspondence should be sent to jmpcc@corvusmedpress.com.